Venous thromboembolism prophylaxis practices for patients with sickle cell disease prior to and during the COVID-19 pandemic
Description
Patients with sickle cell disease (SCD) are predisposed to a hypercoagulable state due to alterations in the coagulation system. Despite concern for the development of venous thromboembolism (VTE) in this population, there are no standardized
